Advertisement

Topics

ChemoCentryx, Inc. Company Profile

02:27 EDT 26th March 2019 | BioPortfolio

ChemoCentryx is a focused pharmaceutical company creating first-in-class, orally available medicines for autoimmune diseases, inflammatory disorders and oncology.
By leveraging our pioneering expertise in the field of chemokine research, ChemoCentryx has generated a broad portfolio of medicines targeting the chemokine system, with six product candidates currently in pre-clinical and clinical stages of development. Our pipeline includes: Traficet-EN™ currently in Phase II clinical studies and initially being developed for inflammatory bowel disease. Traficet-EN targets a chemokine receptor called CCR9, which regulates the trafficking of inflammatory cells to the digestive tract. In a separate program, ChemoCentryx intends to take a new drug candidate for multiple sclerosis and cardiovascular disease, targeting the receptor CCR2, into clinical trials this year. Also, two promising compounds targeting novel chemokine receptors are in development for the treatment of cancers. Lastly, ChemoCentryx has two partnered programs. A CCR1 antagonist is being co-developed with Forest Laboratories for autoimmune disorders and CXCR3 receptor antagonists are being developed by ChemoCentryx's partner, Amgen-SF (formerly Tularik).

Location

850 Maude Avenue
Mountain View
California
94043
United States of America

Contact

Phone: 650-210-2900
Fax: 650-210-2910


News Articles [17 Associated News Articles listed on BioPortfolio]

ChemoCentryx: Topwirkstoff, Toppartner, topfinanziert und bereit für die erste Zulassung

Chronische Entzündungskrankheiten betreffen 10 % der Bevölkerung in Europa, und der Behandlungsbedarf ist trotz neuer Medikamente extrem hoch. ChemoCentryx (WKN:A0NBM2) kann mit seinen Wirkstoffen ....

#news #biotech ChemoCentryx pulls conditional approval filing to rejig regulatory plan

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: ChemoCentryx pulls conditional approval filing to rejig regulatory plan .Chem...

ChemoCentryx/Vifor Change Tack On EU Avacopan Filing

ChemoCentryx and Vifor Fresenius have changed their conditional marketing authorization application for avacopan to a full MAA in the EU...   

Vifor Pharma expands ChemoCentryx partnership

ChemoCentryx 2018 Q3 - Results - Earnings Call Slides

ChemoCentryx, Inc. 2018 Q4 - Results - Earnings Call Slides

ChemoCentryx, Vifor Fresenius to seek full approval of avacopan next year

ChemoCentryx (CCXI) CEO Thomas Schall on Q3 2018 Results - Earnings Call Transcript

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

A Study to Assess the Relative Bioavailability of Four New Formulations of GSK1605786 in Healthy Subjects

This is an open-label, single dose, randomized, five-period, crossover study in healthy volunteers to assess the relative bioavailability of four GSK developed oral formulations of GSK1605...

Companies [2 Associated Companies listed on BioPortfolio]

ChemoCentryx

ChemoCentryx is a privately held biopharma company specializing in the biology of chemokines, protein hormones that regulate the migration, or trafficking, of white blood cells around the body. Whit...

ChemoCentryx, Inc.

ChemoCentryx is a focused pharmaceutical company creating first-in-class, orally available medicines for autoimmune diseases, inflammatory disorders and oncology. By leveraging our pioneering expertis...

More Information about "ChemoCentryx, Inc." on BioPortfolio

We have published hundreds of ChemoCentryx, Inc. news stories on BioPortfolio along with dozens of ChemoCentryx, Inc. Clinical Trials and PubMed Articles about ChemoCentryx, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ChemoCentryx, Inc. Companies in our database. You can also find out about relevant ChemoCentryx, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cytokine
Cytokines include chemokines, lymphokines, and monokines. Cells of the immune system communicate with one another by releasing and responding to chemical messengers called cytokines. These proteins are secreted by immune cells and act on other cells to...


Corporate Database Quicklinks



Searches Linking to this Company Record